Fetuin-A levels were higher in NAFLD patients than in the controls, independently of age, sex, BMI, insulin resistance, dyslipidemia, adiponectin, PNPLA3 I148M and ALT levels. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.